NCT02602509View on ClinicalTrials.gov

Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Tuberculosis

Interventions

DRUG

Celecoxib

DRUG

Rifampicin

DRUG

Pyrazinamide

Trial Locations (1)

Unknown

National University Hospital, Singapore

All Listed Sponsors

lead

National University Hospital, Singapore

OTHER

NCT02602509 - Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter